Literature DB >> 10037683

The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene.

T Sueyoshi1, T Kawamoto, I Zelko, P Honkakoski, M Negishi.   

Abstract

The endogenous CYP2B6 gene becomes phenobarbital (PB) inducible in androstenol-treated HepG2 cells either transiently or stably transfected with a nuclear receptor CAR expression vector. The PB induction mediated by CAR is regulated by a conserved 51-base pair element called PB-responsive enhancer module (PBREM) that has now been located between -1733 and -1683 bp in the gene's 5'-flanking region. An in vitro translated CAR acting as a retinoid X receptor alpha heterodimer binds directly to the two nuclear receptor sites NR1 and NR2 within PBREM. In a stably transfected HepG2 cell line, both PBREM and NR1 are activated by PB and PB-type compounds such as chlorinated pesticides, polychlorinated biphenyls and chlorpromazine. In addition to PBREM, CAR also transactivates the steroid/rifampicin-response element of the human CYP3A4 gene in HepG2 cells. Thus, activation of the repressed nuclear receptor CAR appears to be a versatile mediator that regulates PB induction of the CYP2B and other genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037683     DOI: 10.1074/jbc.274.10.6043

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  163 in total

1.  A novel drug-regulated gene expression system based on the nuclear receptor constitutive androstane receptor (CAR).

Authors:  P Honkakoski; I Jääskeläinen; M Kortelahti; A Urtti
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

2.  Differential activation of human constitutive androstane receptor and its SV23 and SV24 splice variants by rilpivirine and etravirine.

Authors:  Devinder Sharma; Aik Jiang Lau; Matthew A Sherman; Thomas K H Chang
Journal:  Br J Pharmacol       Date:  2015-02-10       Impact factor: 8.739

3.  Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation.

Authors:  Ryota Shizu; Makoto Osabe; Lalith Perera; Rick Moore; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Mol Cell Biol       Date:  2017-05-02       Impact factor: 4.272

4.  Pregnane X receptor-mediated induction of Cyp3a by black cohosh.

Authors:  Xiaoyan Pang; Jie Cheng; Kristopher W Krausz; De-an Guo; Frank J Gonzalez
Journal:  Xenobiotica       Date:  2010-10-27       Impact factor: 1.908

Review 5.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.

Authors:  Sean Ekins; Leonid Mirny; Erin G Schuetz
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

6.  Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands.

Authors:  Ann M Dring; Linnea E Anderson; Saima Qamar; Matthew A Stoner
Journal:  Chem Biol Interact       Date:  2010-10-20       Impact factor: 5.192

Review 7.  Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.

Authors:  Antonia H Tolson; Hongbing Wang
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

8.  Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.

Authors:  Jennifer M Phillips; Jay I Goodman
Journal:  Toxicol Sci       Date:  2009-02-20       Impact factor: 4.849

Review 9.  The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.

Authors:  Bryan Mackowiak; Jessica Hodge; Sydney Stern; Hongbing Wang
Journal:  Drug Metab Dispos       Date:  2018-05-14       Impact factor: 3.922

10.  Flame retardant BDE-47 effectively activates nuclear receptor CAR in human primary hepatocytes.

Authors:  Tatsuya Sueyoshi; Linhao Li; Hongbing Wang; Rick Moore; Prasada Rao S Kodavanti; Hans-Joachim Lehmler; Masahiko Negishi; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2013-11-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.